dr. mateos on the significance of the canova trial in r/r t(11;14) myeloma
Published 4 years ago • 166 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
2:29
dr. mateos on the ongoing canova trial in t(11;14) multiple myeloma
-
1:27
dr. mateos on frail patients with multiple myeloma in the arrow trial
-
1:49
the importance of mrd assessment in myeloma with prof. mateos
-
1:35
canova: venetoclax dexamethasone for t(11;14) r/r myeloma
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
2:58
safety and efficacy of venetoclax in combination with dex as targeted therapy for pts with t(11;14)
-
1:53
canova trial: vendex versus pomdex in patients with r/r multiple myeloma
-
58:59
ask the doc dermatomyositis edition with dr. tiniakou and dr. kang
-
12:02
participating in a multiple myeloma clinical trial part 1: your questions answered
-
59:53
clinical trials in multiple myeloma
-
8:45
clinical trials’ impact on smoldering myeloma management
-
3:55
overview of the sirius clinical trial in the treatment of multiple myeloma
-
7:45
extrapolating from clinical trials: daratumumab in mm
-
1:21
dr. friedman on the future of selinexor in multiple myeloma
-
20:12
venetoclax for multiple myeloma in the post-canova era: rahul banerjee, md, facp, and andrew yee, md
-
3:37
are there placebos in myeloma clinical trials?
-
5:46
dreamm-7 trial update (belavd vs daravd) in rrmm | maria victoria mateos, md | eha 2024
-
1:09
what are clinical trials in myeloma? #myeloma
-
46:01
clinical trials for multiple myeloma patients (selinexor, car t cell) | donna’s story